Intellectual Property

  • March 09, 2026

    Astellas Prevails In Patent Battle Over Bladder Drug

    A Delaware federal judge has held that Ascent Pharmaceuticals infringed four patents covering bladder medication Myrbetriq held by name-brand drugmaker Astellas Pharma Inc. and rejected Ascent's invalidity defenses.

  • March 09, 2026

    McGuireWoods Beats Sun Pharma's DQ Bid In NJ Suit

    A New Jersey federal court has denied Sun Pharmaceutical's bid to disqualify McGuireWoods LLP from representing pharmaceutical company Biofrontera in litigation over the alleged breach of a settlement agreement, ruling the firm's continued representation won't harm Sun Pharmaceutical and will avoid significant harm to Biofrontera.

  • March 09, 2026

    Musicians Claim Google Stole Songs For AI Music Tool

    A group of independent musicians from around the U.S. have sued Google in Chicago federal court, accusing it of copying millions of copyrighted songs and lyrics from YouTube and across the internet to build its AI music generator Lyria 3 — a product the plaintiffs say directly competes with human artists.

  • March 09, 2026

    Golf Co. Approved For $35.7M Ch. 11 Sale To Nicklaus Family

    A Delaware federal bankruptcy judge approved a $35.7 million sale of assets Monday in the Chapter 11 case of sports gear and golf course design enterprise Nicklaus Cos. LLC, agreeing to a deal that will see affiliates tied to retired golfer Jack Nicklaus acquire the business and end protracted litigation among its founders.

  • March 09, 2026

    Catching Up With Delaware's Chancery Court

    The Delaware Chancery Court's docket last week featured disputes spanning alleged forged board approvals at a telecom startup, evidence-destruction claims tied to WWE's blockbuster merger with UFC and investor scrutiny of a multibillion-dollar deal between Intel and the U.S. government.

  • March 09, 2026

    Arnold & Porter Hires RE, IP Attys For West Coast Offices

    Arnold & Porter hired an experienced real estate finance attorney and a veteran IP attorney for partner and counsel roles in its Seattle and San Francisco offices respectively, the firm announced Monday.

  • March 09, 2026

    Texas Jury Finds Lyft Owes $1M In Ride-Hailing Patent Case

    A Texas federal jury said Lyft owes $1 million to Quartz Auto Technologies, finding the ride-hailing giant was liable for infringing an automobile technology patent.

  • March 09, 2026

    Justices Won't Review Fight Over PTAB Prior Art Dates

    The U.S. Supreme Court on Monday denied Lynk Labs Inc.'s petition arguing the Federal Circuit erred in deciding what date should apply to determine whether a patent application constitutes prior art.

  • March 09, 2026

    Supreme Court Lets 'Zioness' TM Co‑Ownership Stand

    The U.S. Supreme Court on Monday declined an appeal that asked the justices to answer whether separate entities can own the same trademark, after the Second Circuit upheld a New York jury verdict that said two nonprofits both owned the mark for "Zioness."

  • March 06, 2026

    Samsung's $303M Loss Looms Over PTAB, Trial Appeals

    The Federal Circuit heard back-to-back-to-back-to-back arguments Friday in Netlist's patent litigation with Samsung, with Netlist trying to revive its server memory patents from Patent Trial and Appeal Board losses, and Samsung trying to lessen a jury's $303 million infringement verdict.

  • March 06, 2026

    Inventor Calls On Justices To End Prosecution Laches

    Prolific inventor Gilbert Hyatt wants the U.S. Supreme Court to take up his challenge to a doctrine that can render a patent unenforceable based on delays by the owner during prosecution, saying the U.S. Patent and Trademark Office is wrongly using the principle to kill applications.

  • March 06, 2026

    Gilstrap Rules Patent Covers Basic Conversation

    A Texas federal judge dismissed a patent infringement suit by Random Chat LLC against Altra Federal Credit Union on Friday, saying the asserted patent claim merely covers the "concept of striking up a random conversation in the real world."

  • March 06, 2026

    Actelion Pays $65M To Settle Tracleer Antitrust Class Suit

    Actelion Pharmaceuticals Ltd. agreed to pay $65 million to resolve antitrust claims from a certified class accusing it of illegally denying generics companies the samples they need to produce generic versions of its hypertension drug Tracleer, according to a brief in Maryland federal court seeking preliminary approval of the settlement.

  • March 06, 2026

    Judge Says Palantir Noncompete Language Is Too Restrictive

    A Manhattan federal judge who ruled last month that three former Palantir employees could keep working at a rival artificial intelligence business has said in his unsealed opinion that while evidence showed the defendants may have solicited colleagues and mishandled company files, Palantir's noncompete restrictions were overbroad.

  • March 06, 2026

    Ex-Exec Can't Skirt Ammo Tech Secrets Suit, NC Judge Says

    A former director and plant manager at track-and-trace company Jekson USA Inc. couldn't secure a pretrial exit, a North Carolina Business Court judge has said, ruling the company pled its trade secret and contract breach claims with enough specificity.

  • March 06, 2026

    Cyntec Gets Calif. Jury To Uphold Patents In Infringement Suit

    A California federal jury has upheld claims in a pair of Cyntec Co. patents for electrical circuit technology, years after Chilisin Electronics Corp. was put on the hook for infringing the patents.

  • March 06, 2026

    Fed. Circ. Revives Damages Dispute In Exafer Case

    The Federal Circuit reopened the damages amount issue in a patent infringement case brought by Israeli company Exafer Ltd. against Microsoft Corp. on Friday, saying a district judge was wrong to exclude the opinions of an Exafer damages expert.

  • March 06, 2026

    Fed. Circ. Won't Reinstate $2M Sepsis-Testing Patent Verdict

    The Federal Circuit on Friday refused to revive the $2 million jury verdict Magnolia Medical Technologies Inc. won in its sepsis-testing patent infringement suit against Kurin Inc., affirming a Delaware federal judge's decision to throw out the verdict after trial.

  • March 06, 2026

    Publishers Sue 'Shadow Library' For 'Staggering' Book Piracy

    Thirteen of the biggest book publishers in the U.S. filed a copyright lawsuit against Anna's Archive on Friday, accusing the so-called shadow library of operating one of the world's largest piracy sites and offering high-speed access to its repository of books and academic papers to AI developers.

  • March 06, 2026

    Ad.com Says Insurer Owes Defense Of TM Suit

    An Arizona insurer wrongfully refused to insure the interactive advertising company Ad.com against a trademark lawsuit from a pair of technology companies accusing the advertiser of stealing their brand identifiers to sell its own product, Ad.com alleged in a lawsuit this week. 

  • March 06, 2026

    Mitchell Silberberg Taps New DC Office Managing Partner

    A longtime intellectual property and litigation partner at Mitchell Silberberg & Knupp LLP has been tapped as the new leader of its Washington, D.C., office, a decision the firm says fits its strategic plan to invest in leadership and enhance collaboration, the firm announced Thursday.

  • March 06, 2026

    Fortnite Maker Says Ex-Contractor Leaked Secrets For 'Clout'

    Fortnite maker Epic Games Inc. accused a former contractor of anonymously leaking company secrets on social media, violating his nondisclosure agreement and jeopardizing the gaming company's business relationships, according to a lawsuit filed in North Carolina federal court.

  • March 06, 2026

    UK Litigation Roundup: Here's What You Missed In London

    This past week in London has seen British American Tobacco sued by more than 100 investors, the government bring a claim against a COVID-19 supplier of personal protective equipment, Annington Funding sue its new corporate trustees on the Financial List, and Piers Morgan hit with a defamation claim from a pro-Israel barrister he interviewed on his YouTube channel. 

  • March 05, 2026

    Telehealth Co. Swaps In Gordon Rees In Novo's GLP-1 Fight

    A telehealth platform facing allegations from Novo Nordisk that it falsely advertised Ozempic alternatives has picked new counsel in the dispute, withdrawing attorneys from Foley & Lardner LLP and Miller Nash LLP and substituting in two lawyers from Gordon Rees Scully Mansukhani LLP.

  • March 05, 2026

    Top Patent Officials To Review Sanofi's Double Patenting Win

    U.S. Patent and Trademark Office Director John Squires on Thursday announced he'll be reviewing whether the Patent Trial and Appeal Board properly approved Sanofi's patent application after an obviousness-type double patenting rejection.

Expert Analysis

  • Latisse Ruling's Lessons On Avoiding Chemical Patent Pitfalls

    Author Photo

    The Federal Circuit's decision in Duke v. Sandoz, reversing a $39 million infringement claim for selling a generic Latisse product, reinforces a fundamental truth in chemical patent strategy: Broad genus claims rarely survive without clear evidence of possession of specific embodiments, says Kimberly Vines at Stites & Harbison.

  • A Redirection For AIA Proceedings Under New USPTO Director

    Author Photo

    A recent U.S. Patent and Trademark Office memorandum implementing a bifurcated process for determining whether to institute an inter partes review or post-grant review, and the new director's subsequent notice of proposed rulemaking with additional limitations on the use of IPRs, may significantly affect patent litigation strategies, say attorneys at Sterne Kessler.

  • Considerations When Invoking The Common-Interest Privilege

    Author Photo

    To successfully leverage the common-interest doctrine in a multiparty transaction or complex litigation, practitioners should be able to demonstrate that the parties intended for it to apply, that an underlying privilege like attorney-client has attached, and guard against disclosures that could waive privilege and defeat its purpose, say attorneys at DLA Piper.

  • Motorola Ruling Solidifies Discretionary Authority Of USPTO

    Author Photo

    The Federal Circuit's latest ruling in In re: Motorola Solutions Inc. underscores the finality and discretionary nature of the finality of Patent Trial and Appeal Board institution decisions, and clarifies that neither interim guidance nor shifting administrative policy creates substantive rights for petitioners, say attorneys at Morgan Lewis.

  • Series

    The Law Firm Merger Diaries: Making The Case To Combine

    Author Photo

    When making the decision to merge, law firm leaders must factor in strategic alignment, cultural compatibility and leadership commitment in order to build a compelling case for combining firms to achieve shared goals and long-term success, says Kevin McLaughlin at UB Greensfelder.

  • How Brand-Entertainment Collabs Are Reshaping IP Strategy

    Author Photo

    As storytelling and commerce become increasingly intertwined, brand and entertainment collaborations demand equal parts creativity and legal precision, and rightsholders that proactively align their IP, clearance and ownership strategies will be best positioned to capture opportunity while mitigating risk, says Bess Morgan at Loeb & Loeb.

  • Opinion

    Despite Deputy AG Remarks, DOJ Can't Sideline DC Bar

    Author Photo

    Deputy Attorney General Todd Blanche’s recent suggestion that the D.C. Bar would be prevented from reviewing misconduct complaints about U.S. Department of Justice attorneys runs contrary to federal statutes, local rules and decades of case law, and sends the troubling message that federal prosecutors are subject to different rules, say attorneys at HWG.

  • How AI Tech Suppliers Can Address IP Lawyers' Concerns

    Author Photo

    While artificial intelligence tools can help intellectual property lawyers be more productive and effective, AI tech providers must address issues of privilege, data privacy and confidentiality to make their technology viable and useful for IP law, say Tom Colson at Colson Law and Kevin Bronson at Simpson & Simpson.

  • How Trial Attys Can Sidestep Opponents' Negative Frames

    Author Photo

    In litigation, attorneys often must deny whatever language or association the other side levies against them, but doing so can make the associations more salient in the minds of fact-finders, so it’s essential to reframe messages in a few practical ways at trial, says Ken Broda-Bahm at Persuasion Strategies.

  • How Store Brand Evolution May Influence IP Cases

    Author Photo

    A consumer shift toward private-label grocery products has spurred a recent crop of lawsuits, like Smuckers v. Trader Joe's, and parties must be prepared to carefully analyze consumer confusion in the grocery retailing context, as well as expectations and behavior, say Justin LaTorraca, Elizabeth Milsark and Laura O’Laughlin at Analysis Group.

  • 8th Circ. Decision Shipwrecks IRS On Shoals Of Loper Bright

    Author Photo

    The Eighth Circuit’s recent decision invalidating transfer pricing regulations in 3M Co. v. Commissioner may be the most significant tax case implementing Loper Bright's rejection of agency deference as a judicial tool in statutory construction, says Edward Froelich at McDermott.

  • Rule Amendments Pave Path For A Privilege Claim 'Offensive'

    Author Photo

    Litigators should consider leveraging forthcoming amendments to the Federal Rules of Civil Procedure, which will require early negotiations of privilege-related discovery claims, by taking an offensive posture toward privilege logs at the outset of discovery, says David Ben-Meir at Ben-Meir Law.

  • IP Ownership Risk Grows In Booming Cancer Drug Market

    Author Photo

    The ownership of intellectual property has become strategically decisive in deals involving valuable cancer therapeutics known as ADCs, as highlighted by the recent Takeda-Innovent deal, with the commercial value of a license resting on the integrity and defensibility of the underlying technology, say attorneys at Loeb & Loeb.

  • Series

    My Miniature Livestock Farm Makes Me A Better Lawyer

    Author Photo

    Raising miniature livestock on my farm, where I am fully present with the animals, is an almost meditative time that allows me to return to work invigorated, ready to juggle numerous responsibilities and motivated to tackle hard issues in new ways, says Ted Kobus at BakerHostetler.

  • The Future Of Gen AI Training Amid Reddit Data Scraping Suit

    Author Photo

    Reddit's lawsuit against Perplexity AI is not framed as a classic copyright infringement fight, demonstrating that even when companies avoid fair use claims, the path by which training data is obtained is legally consequential, say attorneys at Troutman Pepper.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.